Waterfront Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Buy
33,159
+1,414
+4% +$82.4K 0.37% 85
2025
Q4
$1.75M Buy
31,745
+98
+0.3% +$4.71K 0.33% 91
2025
Q3
$1.42M Sell
31,647
-437
-1% -$20.4K 0.29% 105
2025
Q2
$1.49M Sell
32,084
-734
-2% -$36K 0.33% 89
2025
Q1
$2M Buy
32,818
+148
+0.5% +$8.63K 0.49% 57
2024
Q4
$1.85M Buy
32,670
+812
+3% +$45.4K 0.45% 62
2024
Q3
$1.67M Buy
31,858
+7,837
+33% +$368K 0.41% 72
2024
Q2
$998K Buy
24,021
+3,743
+18% +$167K 0.27% 119
2024
Q1
$904K Buy
+20,278
New +$1.03M 0.25% 125
2022
Q1
Sell
-3,850
Closed -$240K 245
2021
Q4
$240K Sell
3,850
-74
-2% -$4.34K 0.1% 199
2021
Q3
$232K Buy
3,924
+100
+3% +$6.59K 0.11% 160
2021
Q2
$256K Buy
+3,824
New +$249K 0.12% 150

Other funds holding BMY

Waterfront Wealth's BMY Position: Q1 2026 in Review

Waterfront Wealth increased its Bristol-Myers Squibb (BMY) stake by 4.5% in Q1 2026, buying an estimated $82.4K and bringing the position to 33,159 shares worth $2.01M. The position accounts for 0.37% of the portfolio, ranked #85.

Waterfront Wealth first reported a position in BMY in Q2 2021 and has held it in 12 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Waterfront Wealth held 33,159 shares of Bristol-Myers Squibb worth $2.01M as of Q1 2026.
  • Waterfront Wealth bought 1,414 Bristol-Myers Squibb shares in Q1 2026, an estimated $82.4K.
  • Bristol-Myers Squibb made up 0.37% of Waterfront Wealth's portfolio in Q1 2026, its #85 holding.
  • Waterfront Wealth first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 12 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Waterfront Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.